Type I and II metabotropic glutamate receptor agonists and antagonists evoke cardiovascular effects after intrathecal administration in conscious rats

Por Li, Xiao C, Beart, Philip M, Monn, James A, Jones, Nicole M, Widdop, Robert E
Publicado em 1999

Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models

Por Johnson, Michael P, Muhlhauser, Mark A, Nisenbaum, Eric S, Simmons, Rosa M A, Forster, Beth M, Knopp, Kelly L, Yang, Lijuan, Morrow, Denise, Li, Dominic L, Kennedy, Jeffrey D, Swanson, Steven, Monn, James A
Publicado no Br J Pharmacol (2017)